| dbo:abstract
|
- Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Berkeley Heights, New Jersey and Dundee, Scotland, developing cancer treatments. Cyclacel was founded in 1996 by David Lane, PhD. (en)
|
| dbo:foundingYear
| |
| dbo:industry
| |
| dbo:keyPerson
| |
| dbo:location
| |
| dbo:netIncome
| |
| dbo:numberOfEmployees
|
- 17 (xsd:nonNegativeInteger)
|
| dbo:product
| |
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 2197 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:foundation
| |
| dbp:homepage
| |
| dbp:industry
| |
| dbp:keyPeople
|
- David P. Lane, PhD, founder (en)
- Mark Kirschbaum, MD, CMO (en)
- Paul McBarron, EVP, Finance & COO (en)
- Spiro Rombotis, CEO (en)
|
| dbp:location
|
- Berkeley Heights, New Jersey, U.S. (en)
|
| dbp:logo
| |
| dbp:name
|
- Cyclacel Pharmaceuticals, Inc. (en)
|
| dbp:netIncome
| |
| dbp:numEmployees
| |
| dbp:products
|
- CYC140 (en)
- Fadraciclib , (en)
|
| dbp:tradedAs
| |
| dbp:type
| |
| dbp:wikiPageUsesTemplate
| |
| dbp:wordnet_type
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Berkeley Heights, New Jersey and Dundee, Scotland, developing cancer treatments. Cyclacel was founded in 1996 by David Lane, PhD. (en)
|
| rdfs:label
| |
| owl:sameAs
| |
| skos:closeMatch
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- Cyclacel Pharmaceuticals, Inc. (en)
|
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
